Associations between mental illness and non-medical use of prescription opioids among a sample of people who use drugs in Australia and New Zealand

References

• Australian Government Department of Health. (2009). Mental disorder comorbidity. https://www1.health.gov.au/internet/publications/publishing.nsf/Content/mental-pubs-m-mhaust2-toc∼mental-pubs-m-mhaust2-hig∼mental-pubs-m-mhaust2-hig-men
   Google Scholar
• Australian Institute of Health and Welfare. (2018a). 3.17 Opioid harm. https://www.aihw.gov.au/getmedia/3a734af9-5ee4-490e-9a8d-2702907aed25/aihw-aus-221-chapter-3-17.pdf.aspx
   Google Scholar
• Australian Institute of Health and Welfare. (2018b). Opioid harm in Australia. https://www.aihw.gov.au/getmedia/605a6cf8-6e53-488e-ac6e-925e9086df33/aihw-hse-210.pdf.aspx?inline=true
   Google Scholar
• Bao, Y., Pan, Y., Taylor, A., Radakrishnan, S., Luo, F., Pincus, H. A., & Schackman, B. R. (2016). Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Affairs (Project Hope), 35(6), 1045–1051. https://doi.org/10.1377/hlthaff.2015.1673
   PubMed Web of Science ®Google Scholar
• Barratt, M. J., Ferris, J. A., Zahnow, R., Palamar, J. J., Maier, L. J., & Winstock, A. R. (2017). Moving on from representativeness: Testing the utility of the global drug survey. Substance Abuse: Research and Treatment, 11, 1178221817716391. https://doi.org/10.1177/1178221817716391
   Web of Science ®Google Scholar
• Barth, K. S., Maria, M. M.-S., Lawson, K., Shaftman, S., Brady, K. T., & Back, S. E. (2013). Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence. American Journal on Addictions, 22(5), 486–491. https://doi.org/10.1111/j.1521-0391.2013.12038.x
   PubMed Web of Science ®Google Scholar
• Bouvier, B. A., Waye, K. M., Elston, B., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2018). Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically. Drug and Alcohol Dependence, 183, 73–77. https://doi.org/10.1016/j.drugalcdep.2017.10.023
   PubMed Web of Science ®Google Scholar
• Brown, R., & Morgan, A. (2019). The opioid epidemic in North America: Implications for Australia. Trends and Issues in crime and criminal justice. No. 578. Australian Institute of Criminology. https://www.aic.gov.au/sites/default/files/2020-05/ti578_the_opioid_epidemic_in_north_america-v2.pdf
   Google Scholar
• Campbell, G., Lintzeris, N., Gisev, N., Larance, B., Pearson, S., & Degenhardt, L. (2019). Regulatory and other responses to the pharmaceutical opioid problem. The Medical Journal of Australia, 210(1), 6–8.e1. https://doi.org/10.5694/mja2.12047
   PubMed Web of Science ®Google Scholar
• Chan, G. C., Leung, J., & Hall, W. (2019). Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates. Drug and Alcohol Review, 38(2), 151–158. https://doi.org/10.1111/dar.12893
   PubMed Web of Science ®Google Scholar
• Chen, Q., Larochelle, M. R., Weaver, D. T., Lietz, A. P., Mueller, P. P., Mercaldo, S., Wakeman, S. E., Freedberg, K. A., Raphel, T. J., Knudsen, A. B., Pandharipande, P. V., & Chhatwal, J. (2019). Prevention of prescription opioid misuse and projected overdose deaths in the United States. JAMA Network Open, 2(2), e187621. https://doi.org/10.1001/jamanetworkopen.2018.7621
   PubMed Web of Science ®Google Scholar
• Cragg, A., Hau, J. P., Woo, S. A., Kitchen, S. A., Liu, C., Doyle-Waters, M. M., & Hohl, C. M. (2019). Risk factors for misuse of prescribed opioids: A systematic review and meta-analysis. Annals of Emergency Medicine, 74(5), 634–646. https://doi.org/10.1016/j.annemergmed.2019.04.019
   PubMed Web of Science ®Google Scholar
• Culpepper, L. (2014). The diagnosis and treatment of bipolar disorder: Decision-making in primary care. Primary Care Companion CNS Disorders, 16(3). https://doi.org/10.4088/PCC.13r01609
   Google Scholar
• Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., & Larney, S. (2019). Global patterns of opioid use and dependence: Harms to populations, interventions, and future action. The Lancet, 394(10208), 1560–1579. https://doi.org/10.1016/S0140-6736(19)32229-9
   PubMed Web of Science ®Google Scholar
• Dertadian, G. C. (2019). A fine line: Painkillers and pleasure in the age of anxiety. Drug and Alcohol Review, 38, 452–453. https://doi.org/10.1111/dar.12926
   Web of Science ®Google Scholar
• Devulapalli, K. K., Ignacio, R. V., Weiden, P., Cassidy, K. A., Williams, T. D., Safavi, R., Blow, F. C., Sajatovic, M. (2010). Why do persons with bipolar disorder stop their medication? Psychopharmacology Bulletin., 43(3), 5–14.
   PubMedGoogle Scholar
• Edmonds, M., Tynan, K., See, N., Maunsell, T., & Snoswell, C. L. (2020). An audit of the quantity of immediate release oxycodone 5 mg tablets prescribed for discharge: An area for improved opioid stewardship? Journal of Pharmacy Practice and Research, 50(5), 413–417. https://doi.org/10.1002/jppr.1678
   Google Scholar
• Ellis, J., & Mullan, J. (2009). Prescription medication borrowing and sharing – Risk factors and management. Australian Family Physician, 38(10), 816–819.
   PubMed Web of Science ®Google Scholar
• Feingold, D., Brill, S., Goor-Aryeh, I., Delayahu, Y., & Lev-Ran, S. (2018). The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study. Journal of Affective Disorders, 235, 293–302. https://doi.org/10.1016/j.jad.2018.04.058
   PubMed Web of Science ®Google Scholar
• Freeman, M. P., & Stoll, A. L. (1998). Mood stabilizer combinations: A review of safety and efficacy. The American Journal of Psychiatry, 155(1), 12–21. https://doi.org/10.1176/ajp.155.1.12
   PubMed Web of Science ®Google Scholar
• Goldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014). Prevalence of axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses. Addictive Behaviors, 39(3), 520–531. https://doi.org/10.1016/j.addbeh.2013.11.022
   PubMed Web of Science ®Google Scholar
• Gros, D. F., Milanak, M. E., Brady, K. T., & Back, S. E. (2013). Frequency and severity of comorbid mood and anxiety disorders in prescription opioid dependence. The American Journal on Addictions, 22(3), 261–265. https://doi.org/10.1111/j.1521-0391.2012.12008.x
   PubMed Web of Science ®Google Scholar
• Guerriero, F. (2017). Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults. World Journal of Clinical Cases, 5(3), 73–81. https://doi.org/10.12998/wjcc.v5.i3.73
   PubMed Web of Science ®Google Scholar
• Haggan, M. (2018). Single ingredient codeine downscheduled. https://ajp.com.au/news/single-ingredient-codeine-downscheduled/
   Google Scholar
• Hernandez, A., Branscum, A. J., Li, J., MacKinnon, N. J., Hincapie, A. L., & Cuadros, D. F. (2020). Epidemiological and geospatial profile of the prescription opioid crisis in Ohio, United States. Scientific Reports, 10(1), 4314. https://doi.org/10.1038/s41598-020-61281-y
   PubMed Web of Science ®Google Scholar
• Hollingworth, S. A., Symons, M., Khatun, M., Loveday, B., Ballantyne, S., Hall, W. D., & Najman, J. M. (2013). Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia. Australian and New Zealand Journal of Public Health, 37(2), 132–138. https://doi.org/10.1111/1753-6405.12030
   PubMed Web of Science ®Google Scholar
• Jones, J. D., Mogali, S., & Comer, S. D. (2012). Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence, 125(1–2), 8–18. https://doi.org/10.1016/j.drugalcdep.2012.07.004
   PubMed Web of Science ®Google Scholar
• Karanges, E. A., Blanch, B., Buckley, N. A., & Pearson, S. A. (2016). Twenty-five years of prescription opioid use in Australia: A whole-of-population analysis using pharmaceutical claims. British Journal of Clinical Pharmacology, 82(1), 255–267. https://doi.org/10.1111/bcp.12937
   PubMed Web of Science ®Google Scholar
• Langford, A. V., Gnjidic, D., Lin, C.-W C., Bero, L., Penm, J., Blyth, F. M., & Schneider, C. R. (2021). Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: A qualitative analysis. BMJ Quality & Safety, 30(2), 133–140. https://doi.org/10.1136/bmjqs-2020-010881
   PubMed Web of Science ®Google Scholar
• Lankenau, S. E., Teti, M., Silva, K., Bloom, J. J., Harocopos, A., & Treese, M. (2012). Initiation into prescription opioid misuse amongst young injection drug users. The International Journal on Drug Policy, 23(1), 37–44. https://doi.org/10.1016/j.drugpo.2011.05.014
   PubMed Web of Science ®Google Scholar
• Martins, S. S., Keyes, K. M., Storr, C. L., Zhu, H., & Chilcoat, H. D. (2009). Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence, 103(1-2), 16–24. https://doi.org/10.1016/j.drugalcdep.2009.01.019
   PubMed Web of Science ®Google Scholar
• Martins, S. S., Storr, C. L., Zhu, H., & Chilcoat, H. D. (2009). Correlates of extramedical use of oxyContin versus other analgesic opioids among the US general population. Drug and Alcohol Dependence, 99(1–3), 58–67. https://doi.org/10.1016/j.drugalcdep.2008.06.013
   PubMed Web of Science ®Google Scholar
• Montes, J. M., Maurino, J., de Dios, C., & Medina, E. (2013). Suboptimal treatment adherence in bipolar disorder: Impact on clinical outcomes and functioning. Patient Preference and Adherence, 7, 89–94. https://doi.org/10.2147/PPA.S39290
   PubMed Web of Science ®Google Scholar
• Morley, K. I., Ferris, J. A., Winstock, A. R., & Lynskey, M. T. (2017). Polysubstance use and misuse or abuse of prescription opioid analgesics: A multi-level analysis of international data. Pain, 158(6), 1138–1144. https://doi.org/10.1097/j.pain.0000000000000892
   PubMed Web of Science ®Google Scholar
• Nielsen, S., Cameron, J., & Pahoki, S. (2013). Opportunities and challenges: Over-the-counter codeine supply from the codeine consumer's perspective. The International Journal of Pharmacy Practice, 21(3), 161–168. https://doi.org/10.1111/j.2042-7174.2012.00247.x
   PubMedGoogle Scholar
• Pergolizzi, J. V., Varrassi, G., Paladini, A., & LeQuang, J. (2019). Stopping or decreasing opioid therapy in patients on chronic opioid therapy. Pain and Therapy, 8(2), 163–176. https://doi.org/10.1007/s40122-019-00135-6
   PubMed Web of Science ®Google Scholar
• Rosenblum, A., Marsch, L. A., Joseph, H., & Portenoy, R. K. (2008). Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Experimental and Clinical Psychopharmacology, 16(5), 405–416. https://doi.org/10.1037/a0013628
   PubMed Web of Science ®Google Scholar
• Shand, F. L., Campbell, G., Hall, W., Lintzeris, N., Cohen, M., & Degenhardt, L. (2013). Real-time monitoring of Schedule 8 medicines in Australia: Evaluation is essential. Medical Journal of Australia, 198(2), 80–81. https://doi.org/10.5694/mja12.10785
   PubMed Web of Science ®Google Scholar
• Shipton, E. E., Shipton, A. J., Williman, J. A., & Shipton, E. A. (2017). Deaths from opioid overdosing: Implications of coroners' inquest reports 2008-2012 and annual rise in opioid prescription rates: A population-based cohort study. Pain and Therapy, 6(2), 203–215. https://doi.org/10.1007/s40122-017-0080-7
   PubMed Web of Science ®Google Scholar
• Therapeutic Goods Administration. ( 2019). Prescription opioids hub Upcoming changes to reduce harm. https://www.tga.gov.au/alert/prescription-opioids-hub
   Google Scholar
• Thompson, W., & Farrell, B. (2013). Deprescribing: What is it and what does the evidence tell us? The Canadian Journal of Hospital Pharmacy, 66(3), 201–202. https://doi.org/10.4212/cjhp.v66i3.1261
   PubMedGoogle Scholar
• Tucker, D., Hayashi, K., Milloy, M. J., Nolan, S., Dong, H., Kerr, T., & Wood, E. (2016). Risk factors associated with benzodiazepine use among people who inject drugs in an urban Canadian setting. Addictive Behaviors, 52, 103–107. https://doi.org/10.1016/j.addbeh.2015.10.002
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. (2019). World Drug Report 2019: 35 Million people worldwide suffer from drug use disorders while only 1 in 7 people receive treatment. https://www.unodc.org/unodc/en/frontpage/2019/June/world-drug-report-2019_-35-million-people-worldwide-suffer-from-drug-use-disorders-while-only-1-in-7-people-receive-treatment.html
   Google Scholar
• Volkow, N. D., & McLellan, A. T. (2016). Opioid abuse in chronic pain – Misconceptions and mitigation strategies. The New England Journal of Medicine, 374(13), 1253–1263. https://doi.org/10.1056/NEJMra1507771
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., Borschmann, R., & Bell, J. (2014). The non-medical use of tramadol in the UK: Findings from a large community sample. International Journal of Clinical Practice, 68(9), 1147–1151. https://doi.org/10.1111/ijcp.12429
   PubMed Web of Science ®Google Scholar